Skip Navigation


JAC Advance Access originally published online on July 12, 2006
Journal of Antimicrobial Chemotherapy 2006 58(4):895; doi:10.1093/jac/dkl276
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
58/4/895    most recent
dkl276v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Shanson, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shanson, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Correspondence

Comment on: Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy

David Shanson*

Department of Medical Microbiology, Great Ormond Street Hospital for Children London WC1N 3JH, UK


*Corresponding author. Tel +44-20-7405-9200; Fax: +44-20-7813-8268; E-mail: davidsha87@hotmail.com

Keywords: BSAC guidelines , prevention , endocarditis , dental procedures

The first 10% of the full text of this article appears below.

Sir,

Appendix 1 of the latest BSAC Working Party Report on Guidelines for the Prevention of Endocarditis1 may be incorrect in implying that there is no risk from any dental procedure to patients with moderate-risk heart lesions and that prophylaxis should be stopped. To state categorically that there is no need for prophylaxis for these patients may be a step . . . [Full Text of this Article]

Transparency declarations


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?